A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis

A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis

Background: Rapidly progressive interstitial lung disease (RP-ILD) is a fatal complication of dermatomyositis (DM) and clinically amyopathic DM (CADM). The objective of this study was to evaluate risk markers associated with RP-ILD incidence in patients with DM/CADM and to develop a RP-ILD risk pred...

Full description

Bibliographic Details
Main Authors: Yimin Li, Yuhui Li, Yuguang Wang, Lianjie Shi, Fuan Lin, Zongxue Zhang, Jingli Zhang, Yanying Liu, Xu Liu, Fangjingwei Xu, Xiaolin Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
dermatomyositis
rapidly progressive interstitial lung disease
risk prediction
risk marker
anti-MDA5 antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.733599/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.733599/full

Similar Items